On one hand, the kidney is thought to be a site of Lp(a) catabolism, and pathological alterations in the kidney, such as those occurring in end-stage renal disease, might lead to decreased excretion of Lp(a) and thus increased Lp(a) levels [30]. The gene discussed is LPA; the disease is stage 5 chronic kidney disease.